The plasma concentration of a PGE2 metabolite was markedly lower in patients with AAA compared to control participants (Figure 1f; p = 0.014), as was activity of the antioxidant enzyme catalase (Figure 1g; p = 0.0096). Here, CAT is linked to triple-A syndrome.